Report of 1,000 Kidney Transplants at the Sungkyunkwan University of Korea

Background: This study aims to report clinical outcome and long term graft and patient survival rate of one thousand kidney transplantation. We analyzed risk factors that impact on graft survival in the 1,000 case of kidney transplantation through this study. Methods: We have performed 1,000 cases of kidney transplantation in Samsung Medical Center, Seoul, Korea from February 1995 to January 2008. We retrospectively reviewed medical record of recipients and donors. Results: The mean follow up period was 69 months. Composition of type of donor was living donor, 653 cases and deceased donor, 347 cases. Type of donor source was mostly living-related type. 94 cases had graft failure. Major cause of graft failure was chronic allograft nephropathy. And major viral infection was cytomegalovirus infection. Major non-viral infection was urinary tract infection. 47 cases of immediate post operative complication was diagnosed as lymphocele. Overall 10-year graft survival rate was 83.9% respectively. 10-year patient survival rate was 95.7% respectively. 10-year graft survival and patient survival of recipient were significantly different between living donation group and deceased donation group. Conclusions: In this report, only two risk factor were statically significant difference.

[1]  F. Ginevri,et al.  Polyomavirus‐Associated Nephropathy , 2009 .

[2]  M. Stegall,et al.  Identifying Specific Causes of Kidney Allograft Loss , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  Xun-bo Jin,et al.  Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. , 2009, Chinese medical journal.

[4]  A. Abdollahi,et al.  Immunosuppressive therapy and post-transplant malignancy. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  A. Lin,et al.  Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation. , 2008, Transplantation proceedings.

[6]  P. Aljama,et al.  Cancer incidence and survival in kidney transplant patients. , 2008, Transplantation proceedings.

[7]  J. Krzesinski,et al.  Polyomavirus in Renal Transplantation: A Hot Problem , 2008, Transplantation.

[8]  H. Meier‐Kriesche,et al.  Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[9]  L. Hilbrands,et al.  Reduced exposure to calcineurin inhibitors in renal transplantation. , 2008, The New England journal of medicine.

[10]  P. Halloran,et al.  Reduced exposure to calcineurin inhibitors in renal transplantation. , 2007, The New England journal of medicine.

[11]  H. Rollag,et al.  The impact of early cytomegalovirus infection and disease in renal transplant recipients. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  G. Opelz,et al.  Kidney graft failure and presensitization against HLA Class I and Class II antigens1 , 2002, Transplantation.